Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.
about
Impact of therapy on genomics and transcriptomics in high-risk prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy.Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4.Beyond the androgen receptor II: New approaches to understanding and treating metastatic prostate cancer; Report from the 2017 Coffey-Holden Prostate Cancer Academy Meeting.Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling.Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation.The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers.Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network.Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.TGFβ signaling limits lineage plasticity in prostate cancer.Genetics and biology of prostate cancerMouse models in the era of large human tumour sequencing studiesA novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network
P2860
Q38607675-F4F2869D-6F48-4CD2-A64D-95EB84B1AB9BQ42071191-AA95FEBA-B92A-4298-9CA7-44A973032096Q43578455-7445DE16-4485-4621-AD58-486AAB334117Q47670505-669BC99D-3AFD-4160-8BA9-6F5609F963C6Q48243350-116F7396-CE0E-41CF-B21E-EDDB178A5DFCQ53682879-863CD161-3557-4F98-8E4A-0CC4ED61BF1AQ53700061-07D4E633-1549-4172-A5B1-F67EE5F95908Q55171826-BE246EBD-CE6B-4C58-A957-33F43E03A481Q55291143-359FC827-7B15-42D9-B70A-D28CFACA0D42Q55461727-E376D5DB-2661-43FE-9CED-FCE0B0DB17ECQ57106917-282CB230-D103-46AF-8C5C-098F05653B02Q58776633-1CA3AC62-4635-4940-ABF8-331041BE49A3Q58788792-D0C20BC3-80BC-4D29-BB16-112A8B1DC3C2
P2860
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Transdifferentiation as a Mech ...... ion-Resistant Prostate Cancer.
@en
type
label
Transdifferentiation as a Mech ...... ion-Resistant Prostate Cancer.
@en
prefLabel
Transdifferentiation as a Mech ...... ion-Resistant Prostate Cancer.
@en
P2093
P2860
P50
P1433
P1476
Transdifferentiation as a Mech ...... tion-Resistant Prostate Cancer
@en
P2093
Antonina Mitrofanova
Cory Abate-Shen
Daniel Chester
Elahe A Mostaghel
Mark A Rubin
Nicolas Floch
Roxanne Toivanen
Sheida Hayati
Yanping Sun
P2860
P304
P356
10.1158/2159-8290.CD-16-1174
P577
2017-04-14T00:00:00Z